Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001042167-24-000067
Filing Date
2024-10-17
Accepted
2024-10-17 11:15:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5171
  Complete submission text file 0001042167-24-000067.txt   7066
Mailing Address 315 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94104
Business Address 315 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94104 (800) 304-9888
GT Biopharma, Inc. (Subject) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-32837 | Film No.: 241376446
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address
Business Address 353 NASSAU ST PRINCETON NJ 08540 6096835883
CYTOVANCE BIOLOGICS INC (Filed by) CIK: 0001231100 (see all company filings)

EIN.: 000000000
Type: SCHEDULE 13G/A